Independence Bank of Kentucky’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $447K | Sell |
7,756
-1,000
| -11% | -$57.4K | 0.05% | 223 |
|
|
2026
Q1 | $531K | Sell |
8,756
-2,537
| -22% | -$148K | 0.07% | 204 |
|
|
2025
Q4 | $609K | Sell |
11,293
-349
| -3% | -$16.8K | 0.08% | 189 |
|
|
2025
Q3 | $525K | Buy |
11,642
+1,475
| +15% | +$68.9K | 0.07% | 203 |
|
|
2025
Q2 | $471K | Sell |
10,167
-331
| -3% | -$16.2K | 0.07% | 198 |
|
|
2025
Q1 | $640K | Sell |
10,498
-99
| -0.9% | -$5.77K | 0.1% | 177 |
|
|
2024
Q4 | $599K | Buy |
10,597
+925
| +10% | +$51.7K | 0.09% | 178 |
|
|
2024
Q3 | $500K | Sell |
9,672
-3,639
| -27% | -$171K | 0.11% | 177 |
|
|
2024
Q2 | $553K | Buy |
13,311
+2,755
| +26% | +$123K | 0.15% | 150 |
|
|
2024
Q1 | $572K | Buy |
10,556
+308
| +3% | +$15.7K | 0.17% | 139 |
|
|
2023
Q4 | $526K | Sell |
10,248
-1,432
| -12% | -$75.2K | 0.18% | 131 |
|
|
2023
Q3 | $678K | Sell |
11,680
-5,245
| -31% | -$321K | 0.29% | 83 |
|
|
2023
Q2 | $1.08M | Sell |
16,925
-705
| -4% | -$47.3K | 0.44% | 68 |
|
|
2023
Q1 | $1.22M | Sell |
17,630
-140
| -0.8% | -$9.87K | 0.53% | 61 |
|
|
2022
Q4 | $1.28M | Sell |
17,770
-25
| -0.1% | -$1.89K | 0.57% | 53 |
|
|
2022
Q3 | $1.26M | Buy |
17,795
+245
| +1% | +$17.8K | 0.62% | 51 |
|
|
2022
Q2 | $1.35M | Sell |
17,550
-1,444
| -8% | -$110K | 0.6% | 54 |
|
|
2022
Q1 | $1.39M | Buy |
18,994
+555
| +3% | +$37.3K | 0.55% | 56 |
|
|
2021
Q4 | $1.15M | Buy |
18,439
+2,425
| +15% | +$142K | 0.47% | 62 |
|
|
2021
Q3 | $948K | Buy |
16,014
+115
| +0.7% | +$7.57K | 0.41% | 72 |
|
|
2021
Q2 | $1.06M | Sell |
15,899
-540
| -3% | -$35.2K | 0.47% | 62 |
|
|
2021
Q1 | $1.04M | Buy |
16,439
+2,890
| +21% | +$180K | 0.5% | 62 |
|
|
2020
Q4 | $840K | Buy |
13,549
+25
| +0.2% | +$1.54K | 0.44% | 71 |
|
|
2020
Q3 | $815K | Buy |
13,524
+1,640
| +14% | +$98.7K | 0.46% | 68 |
|
|
2020
Q2 | $699K | Buy |
11,884
+1,495
| +14% | +$89.4K | 0.45% | 69 |
|
|
2020
Q1 | $579K | Sell |
10,389
-50
| -0.5% | -$3.06K | 0.45% | 66 |
|
|
2019
Q4 | $670K | Buy |
10,439
+3,036
| +41% | +$174K | 0.43% | 68 |
|
|
2019
Q3 | $375K | Buy |
7,403
+1,825
| +33% | +$85.8K | 0.27% | 85 |
|
|
2019
Q2 | $253K | Buy |
5,578
+425
| +8% | +$19.8K | 0.2% | 101 |
|
|
2019
Q1 | $246K | Sell |
5,153
-12,845
| -71% | -$640K | 0.2% | 99 |
|
|
2018
Q4 | $936K | Buy |
17,998
+4,105
| +30% | +$221K | 0.85% | 41 |
|
|
2018
Q3 | $862K | Buy |
13,893
+320
| +2% | +$19K | 0.68% | 45 |
|
|
2018
Q2 | $751K | Buy |
13,573
+2,145
| +19% | +$116K | 0.63% | 47 |
|
|
2018
Q1 | $723K | Sell |
11,428
-1,322
| -10% | -$85K | 0.62% | 48 |
|
|
2017
Q4 | $781K | Buy |
+12,750
| New | +$797K | 0.67% | 43 |
|
Other funds holding BMY
Independence Bank of Kentucky's BMY Position: Q2 2026 in Review
Independence Bank of Kentucky reduced its Bristol-Myers Squibb (BMY) stake by 11% in Q2 2026, selling an estimated $57.4K and leaving 7,756 shares worth $447K. The position accounts for 0.05% of the portfolio, ranked #223.
Independence Bank of Kentucky first reported a position in BMY in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.39M in Q1 2022. 1,603 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Independence Bank of Kentucky held 7,756 shares of Bristol-Myers Squibb worth $447K as of Q2 2026.
- Independence Bank of Kentucky sold 1,000 Bristol-Myers Squibb shares in Q2 2026, an estimated $57.4K.
- Bristol-Myers Squibb made up 0.05% of Independence Bank of Kentucky's portfolio in Q2 2026, its #223 holding.
- Independence Bank of Kentucky first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 35 quarters since.
- Independence Bank of Kentucky's Bristol-Myers Squibb position peaked at $1.39M in Q1 2022.
- 1,603 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.